Background: Essential fatty acid (EFA) deficiency induces fat malabsorption, but the
Fat malabsorption in essential fatty acid-deficient mice is not due toimpaired bile formation
INTRODUCTION
Essential fatty acid (EFA) deficiency has been associated with several pathological consequences in humans and in experimental animals, including fat malabsorption (1) (2) (3) (4) (5) . The pathophysiological mechanisms underlying EFA deficiency-induced fat malabsorption have not been elucidated. To address this issue, the consecutive intraluminal and intracellular steps in the absorption process have been investigated in control and EFA-deficient rats, i.e., lipolysis of dietary triglycerides by lipases, solubilization of lipolytic products by bile components, uptake by the enterocyte and intracellular re-esterification to triglycerides and, finally, chylomicron formation and secretion into lymph (3;4) . Available data from rat models of EFA deficiency have indicated that neither fat digestion nor fatty acid uptake by the enterocyte is responsible for the fat malabsorption encountered in EFA deficiency (3;4) . In rats, EFA deficiency resulted in significantly decreased bile flow and biliary secretion of bile salts, phospholipids (PL) and cholesterol (3;6) . Acyl chain analysis of biliary PL from EFA-deficient rats revealed that biliary PL contents of linoleic acid (C18:2n-6) and arachidonic acid (C20:4n-6) were decreased to 10% and 26% of control values, respectively, and were replaced by oleic acid (C18:1n-9) (4) . In addition to alterations in bile, intracellular events such as fatty acid re-esterification and chylomicron production were severely impaired (3;4) . It thus seems that EFA deficiency in rats affects bile formation and/or intracellular processing of fat by the enterocyte, resulting in fat malabsorption. In a previous study we demonstrated the role of biliary phospholipids in intestinal chylomicron formation, using Mdr2 -/-mice (gene symbol: ABC-B4) which are unable to secrete phospholipids into bile (7;8) . We reasoned that this animal model could be important to further delineate the pathophysiological mechanism of EFA deficiencyinduced fat malabsorption.
If altered biliary phospholipid secretion were involved in EFA deficiency-associated fat malabsorption, one would expect fat absorption in Mdr2 -/-mice to be relatively unaffected by changes in EFA status. If, however, the pathophysiological mechanism would not involve alterations in biliary phospholipid secretion, EFA deficiency would be expected to equally affect the process in Mdr2 -/-and in wildtype mice. In the present study we investigated the role of bile formation in general and of biliary phospholipid secretion in particular, in the pathophysiology of EFA deficiency-associated fat malabsorption. We first developed and characterized a murine model for EFA deficiency with respect to fat absorption and bile formation. Then, we compared fat absorption and bile formation in EFA-deficient and EFA-sufficient Mdr2 -/-mice.
MATERIALS AND METHODS

Animals
Mice homozygous for disruption of the multidrug resistance gene-2 (Mdr2 -/-) and wildtype (Mdr2 +/+ ) mice with a free virus breed (FVB) background were obtained from the breeding colony at the Central Animal Facility, Academic Medical Center, Amsterdam, the Netherlands (9) . All mice were 2-4 months old and weighed 25-30 g.
Mice were housed in a light controlled (lights on 6 AM -6 PM) and temperature controlled (21°C) facility and allowed tap water and chow (Hope Farms B.V. Woerden, the Netherlands) ad libitum. The experimental protocol was approved by the Ethics Committee for Animal Experiments, Faculty of Medical Sciences, University of Groningen, the Netherlands.
Experimental procedures
Fat absorption and bile secretion in EFA-deficient mice FVB mice (n=14) were fed standard low-fat chow (6 weight% fat, 14 energy% fat) for standardization for one month, after which they were anesthetized with halothane and a baseline blood sample was obtained by tail bleeding for determination of EFA status. Blood was collected in micro-hematocrit tubes containing heparin, and plasma was separated by centrifugation at 9000 rpm for 10 min (Eppendorf centrifuge, Eppendorf, Germany) and stored at -20°C until analysis. Subsequently, mice were randomly assigned to either an EFA-sufficient (EFAS) or an EFA-deficient (EFAD) diet. The EFAS and EFAD diets were isocaloric and contained 16 weight% fat. The EFAS chow contained 20 energy%, 34 energy% and 46 energy% from protein, fat and carbohydrate, respectively, and had the following fatty acid profile: 32 mol% palmitic acid (C16:0), 6 mol% stearic acid (C18:0), 32 mol% oleic acid (C18:1n-9), and 30 mol% linoleic acid (C18:2n-6) (custom synthesis, Hope Farms BV, Woerden, the Netherlands). The EFAD diet had identical energy percentages derived from protein, fat and carbohydrate, and had the following fatty acid composition: 41 mol% C16:0, 48 mol% C18:0, 8 mol% C18:1n-9, and 3 mol% C18:2n-6) (custom synthesis, Hope Farms BV, Woerden, the Netherlands). At 2-weekly intervals, blood samples were taken in the manner described above. After 4 and 8 weeks of experimental diet, a 72h fecal fat balance was performed involving quantitative feces collection and determination of chow intake. At 8 weeks, mice were anaesthetized by intraperitoneal injection of Hypnorm (fentanyl/fluanisone) and diazepam, and gallbladders were cannulated for collection of bile for 1h as described previously (10) . At the end of bile collection, a large blood sample (0.6-1.0 ml) was obtained by heart puncture.
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Hepatic expression of Cyp7A and Cyp27
A separate group of male FVB mice was fed EFA-containing or EFA-deficient chow for 8 weeks (n=6 per dietary group). After 8 weeks, animals were anaesthetized with halothane and blood was collected by cardiac puncture for lipid analysis. Livers were removed and liver samples were immediately frozen in liquid nitrogen, and stored at -80°C for determination of mRNA levels of two key enzymes in bile salt biosynthesis, cholesterol 7-alpha-hydroxylase (Cyp7A) and sterol 27-hydroxylase (Cyp27). 
Plasma appearance of retinyl-palmitate after retinol administration
In addition to the absorption of fatty acids during EFA deficiency, the plasma appearance of the less polar lipid molecule retinol (vitamin A) was investigated.
Retinol (5000 IU) in an olive oil bolus (100 µL per mouse) was administered intragastrically to EFA-deficient mice and control mice (n=7 per group) and blood samples were taken at 0, 2 and 4 hours after bolus administration.
Fat absorption and bile secretion in EFA-deficient Mdr2 -/-mice
Mdr2
-/-mice (n=14) were fed low-fat chow (6 weight% fat, 14 energy% fat) for standardization for one month. Baseline blood samples were taken for determination of plasma EFA status, after which mice were randomly assigned to either the EFAcontaining or the EFA-deficient diet. The diets were identical to those described above. After eight weeks of feeding the respective diets, blood samples were obtained by tail bleeding under halothane anesthesia. As in the wildtype mice, fat absorption was measured by means of a 72h fecal fat balance. Retinol in a bolus of olive oil was administered intragastrically to EFA-deficient Mdr2 -/-mice (n=7) and their EFA-sufficient controls (n=7). Blood samples were taken at 0, 2 and 4 hours after bolus administration. Gallbladders were cannulated and bile was collected for 1h as described above (10) . At the end of bile collection, mice were sacrificed after obtaining a large blood sample (0.6-1.0 ml) by heart puncture.
Analytical techniques
Fatty acid status was analyzed by extracting, hydrolyzing and methylating total plasma lipids, liver homogenates and biliary lipids according to the method described by Lepage and Roy (11) . To account for losses during lipid extraction, heptadecanoic acid (C17:0) was added to all samples as an internal standard prior to extraction and methylation procedures, and BHT was added as an antioxidant.
Fatty acid methyl esters were separated and quantified by gas liquid chromatography on a Hewlett Packard gas chromatograph model 6890, equipped with a 50mx0.2mm Ultra 1 capillary column (Hewlett Packard, Palo Alto, CA) and a FID detector. The injector and detector were set at 260°C and 250°C, respectively. The oven temperature was programmed from an initial temperature of 160°C to a final temperature of 290°C in 3 temperature steps (160°C held 2 min; 160-240°C, ramp 2°C/min, held 1 min; 240-290°C, ramp 10°C/min, held 10 min). Helium was used as a carrier gas with a constant flow rate of 0.5 ml per minute. Individual fatty acid methyl esters were quantified by relating the areas of their chromatogram peaks to that of the internal standard heptadecanoic acid (C17:0).
Plasma lipid levels (cholesterol, HDL-cholesterol, triglycerides, free fatty acids and phospholipids) were measured using commercially available kits (Roche Diagnostics, Mannheim resp. WAKO Chemicals Neuss, Germany) according to the instructions provided. Cholesterol, cholesterol ester and triglycerides in liver tissue were determined after Bligh and Dyer lipid extraction (12) and biliary bile salt composition was measured as described previously. Total protein concentrations of liver homogenates were determined according to the method described by Lowry et al. (13) . Total RNA was isolated from liver tissue using Trizol Reagent (GIBCO BRL, Grand Island, NY) according to the manufacturer's instructions. Single stranded cDNA was synthesized from 4.5 g RNA and subsequently subjected to quantitative real-time detection RT-PCR (14;15) . The following primers and probes were used: for Cyp7A Feces and chow pellets were freeze-dried and then mechanically homogenized.
From aliquots of each, lipids were extracted, hydrolyzed and methylated (11) . Resulting fatty acid methyl esters were analyzed by gas chromatography for their fatty acid content as described previously (16) . Fatty acids were quantified using heptadecanoic acid (C17:0) as internal standard.
Retinyl palmitate concentrations in plasma were determined after two extractions with hexane (17) . Retinyl acetate was added to plasma samples as an internal standard before lipid extraction. Samples were resuspended in ethanol and analyzed by reverse-phase HPLC using a 150 x 4,6 mm Symmetry RP18 column (Waters Corp., Milford, MA, USA) (18) . Peak area of retinyl palmitate was normalized to that of retinyl acetate. At each time point, concentrations were expressed as µmol retinyl palmitate per L plasma.
Calculations
Fatty acid status in plasma and in bile
Relative concentrations (mol%) of plasma, liver and biliary phospholipid fatty acids were calculated using the summed areas of major fatty acid peaks (palmitic, stearic, oleic, linoleic acids) and then expressing the area of each individual fatty acid as a percentage of this amount. EFA deficiency was determined by calculating the triene /tetraene ratio (C20:3n-9/C20:4n-6) in plasma of mice. A ratio of >0.2 was considered deficient (19) .
Fatty acid absorption using 72h balance techniques
Absorption of major dietary fatty acids (palmitic, stearic, oleic, linoleic acids) was determined by subtracting the amount of each individual fatty acid excreted in feces in 72h, from the amount of this dietary fatty acid ingested in 72h (net fat absorption).
This quantity was subsequently expressed as a percentage of the amount of fatty acid ingested in 72h (coefficient of fat absorption; 100-fold the ratio between (amount ingested -amount recovered in feces) and the amount ingested). Net amount of fat absorption was calculated by subtracting the fecal loss of the four major fatty acids from the amount ingested.
Statistics
All results are presented as means ± S.D. for the number of animals indicated. Data were statistically analyzed using Student's two-tailed t test. The level of significance for all statistical analysis was set at p<0.05. Analyses were performed using SPSS for Windows software (SPSS, Chicago, IL).
RESULTS
Body weight and chow ingestion in EFA-deficient and EFA-sufficient wildtype mice Body weight was monitored at the start of experimental feeding, and then every two 
Essential fatty acid status
Triene/tetraene ratio in plasma and in liver
The classical biochemical parameter describing EFA status, the triene/tetraene ratio (C20:3n-9/C20:4n-6), was measured in plasma at baseline and every two weeks for eight weeks, and in liver after eight weeks of feeding EFA-deficient chow. Baseline plasma triene/tetraene ratio was 0.02±0.00, which is well below the cutoff value for EFA deficiency (0.20). Already after two weeks on EFA-deficient diet, plasma triene/tetraene ratios reached the cutoff-value for EFA deficiency, i.e., 0.19±0.08 for EFAD chow-fed mice vs. 0.01±0.00 for controls. After eight weeks on EFAD chow, mice had a pronounced EFA deficiency with triene/tetraene ratios of 0.66±0.05 for plasma and 0.56±0.09 for liver, in contrast to control mice (0.01±0.00 for plasma, p<0.001 and 0.02±0.00 for liver, p<0.001) (data not shown)
Characterization of EFA deficiency in mice
Since EFA deficiency has not been characterized before in a murine model, plasma and liver lipids were measured. No differences were found in cholesterol, HDLcholesterol, free fatty acid or phospholipid concentrations in plasma between EFAS and EFAD diet-fed mice (Table 1) . Plasma triglyceride concentrations were decreased in EFA-deficient mice compared with mice fed EFA-containing chow (p<0.001). Liver fat analysis revealed a significant fat accumulation (triglyceride, unesterified cholesterol, cholesterol ester) in EFA-deficient mice compared with their EFA-sufficient counterparts (Table 2) .
Fat absorption
Fecal fatty acid balance
The fecal fat balance revealed a decreased absorption of total dietary fat in EFAD mice compared with their EFAS controls (p<0.01) (Figure 1 ). The absorption coefficient for EFAD mice was 70.1±1.6%, compared with absorption coefficients above 95% for mice fed EFA-containing chow. Individual fatty acid balances for palmitic, stearic, oleic and linoleic acids were calculated (Figure 1) . In EFAD mice, absorption of saturated fatty acids (palmitic and stearic acids) was more affected than absorption of unsaturated fatty acids (oleic and linoleic acids). Table 3 shows that bile flow and biliary secretion of bile salt, cholesterol and phospholipid during a 1h period immediately after interruption of the enterohepatic circulation were higher in EFA-deficient mice compared with controls (for each parameter, p<0.001). Theoretically, alterations in bile salt hydrophobicity could contribute to fat malabsorption in EFA deficiency. However, bile salt composition appeared to be similar between both dietary groups (Table 4) . Concentrations are in mM, * p<0.001; n=7 mice / group. Concentrations are given in nmol/mg protein; * p<0.001; n=7 mice per group.
Bile secretion and composition
35.8 ± 9.4 * 8.0 ± 2.0 Cholesterol esters 75.6 ± 5.3 * 34.9 ± 2.7 Total cholesterol 219.9 ± 27.8 * 151.9 ± 21.8 Triglyceride EFA D EFAS 35.8 ± 9.4 * 8.0 ± 2.0 Cholesterol esters 75.6 ± 5.3 * 34.9 ± 2.7 Total cholesterol 219.9 ± 27.8 * 151.9 ± 21.8 Triglyceride EFA D EFAS 3.11 ± 0.17 2.84 ± 0.44 Phospholipids 0.60 ± 0.04 0.58 ± 0.
1
EFA deficiency-associated changes in acyl chain composition of biliary PL were analyzed by gas chromatography. Relative concentrations (mol%) of C16:1n-7, C18:1n-9 and C18:1n-7 were higher (p<0.001) and concentrations of C16:0, C18:2n-6, C18:0 and C20:4n-6 were lower (p<0.05) in bile of EFA-deficient mice compared to mice fed EFA-containing chow (data not shown).
Cyp7A and Cyp27 mRNA levels
To determine whether the increased bile salt secretion in EFA-deficient mice might be due to increased hepatic bile salt synthesis, hepatic mRNA levels of Cyp7A and 
Plasma appearance of retinyl-palmitate after retinol administration
The absorption of dietary oleic acid, a polar lipid (class III, soluble amphiphile) (20) was only mildly impaired in EFA-deficient mice (Figure 1) . In a separate experiment we No significant difference in chow intake was observed between the two dietary groups after four or eight weeks on either diet (data not shown).
Essential fatty acid status
Triene/tetraene ratio in plasma and in liver
The baseline triene/tetraene ratios (C20:3n-9/C20:4n-6) in plasma and liver were significantly higher in Mdr2 -/-compared to Mdr2 +/+ mice (0.035±0.003 vs. 0.018±0.001, p<0.001), but were still well below the cutoff value for EFA deficiency (0.2). Mdr2 
Characterization of EFA deficiency in Mdr2
-/-mice Plasma concentrations of cholesterol and phospholipid were increased, whereas the plasma triglyceride level was decreased in EFA-deficient Mdr2 -/-mice compared to their EFA-sufficient controls (p<0.05) ( Table 5 ). Similar to the situation in wildtype mice, a pronounced hepatic fat accumulation characterized by increased levels of triglyceride, unesterified and esterified cholesterol, was observed in EFA-deficient
Mdr2
-/-mice (Table 6) . (Table 8) . Concentrations are in mM, * p<0.05; n=7 mice / group. 
EFAD EFAS
DISCUSSION
We investigated the mechanism of fat malabsorption in EFA deficiency in mice, with particular emphasis on the possible role of altered bile formation as proposed by Levy et al. based on studies in rats (3;6) . In order to specify the contribution of biliary phospholipid secretion, studies were performed in EFA-deficient and EFA-sufficient wildtype and Mdr2 -/-mice; the latter are unable to secrete phospholipids into their
bile. Yet, we first had to develop and characterize a murine model for EFA deficiency.
Our data indicate that dietary fat absorption is reduced in EFA-deficient mice compared to EFA-sufficient controls. The mechanism underlying this EFA deficiencyassociated fat malabsorption does not likely involve alterations in bile formation (including bile flow, bile salt secretion rate, bile salt composition or phospholipid secretion rate) nor changes in fat digestion (lipolysis). Rather, our data strongly indicate that EFA deficiency in mice affects intracellular events of fat absorption that occur in the enterocyte.
Biochemical EFA deficiency, conventionally defined by a molar ratio of eicosatrienoic acid (C20:3n-9) and arachidonic acid (C20:4n-6) above 0.20 in plasma (19) , was already reached after only 2 weeks of EFA-deficient diet feeding to mice. This rapidity of onset makes the mouse an attractive and versatile model for studying EFA deficiency.
Similar to EFA-deficient rats (21;22) , EFA-deficient mice experienced changes in plasma and liver fat contents. Specifically, EFA-deficient mice have decreased plasma triglycerides and increased hepatic triglyceride and cholesterol levels. In EFAdeficient rats, Wanon et al. (23) observed alterations in HDL-composition, with defective translocation of HDL-cholesterol into bile and concomitantly increased hepatic VLDL- cholesterol secretion. Lipoprotein abnormalities were also found by Levy et al. (24) in EFA-deficient cystic fibrosis (CF) patients. Compared to their EFA-sufficient counterparts, EFA-deficient CF-patients had increased plasma triglyceride levels (specifically in the VLDL, LDL, HDL2 and HDL3 fractions), and decreased plasma HDL-and LDL-cholesterol. Also, lipoprotein size was altered in these EFA-deficient patients, with larger VLDL, LDL, and HDL2 particles and smaller HDL3 particles.
It could be speculated that EFA, as constituents of triglycerides, phospholipids and cholesterol esters, may be essential for regulation of lipoprotein metabolism.
Although the effects of EFA-deficiency are species specific, it appears that an adequate EFA-status is required for efficient intestinal and hepatic processing of lipoproteins.
In addition to the changes in plasma and liver lipids, EFA deficiency in mice was associated with fat malabsorption. The coefficients of fat absorption in EFA-deficient mice (60-70%) were somewhat lower than corresponding values in EFA-deficient rats (80-90%) (2;4;5) . In all of these studies, EFA deficiency was induced by feeding the animals high-fat EFA-deficient diets almost entirely composed of saturated fatty acids.
Apart from species specificity, the difference in coefficients of fat absorption could be related to the amount and type of fat in the diet. In the present study, mice were fed high fat chow (16 weight%) whereas Hjelte et al. (2) used chow diets containing only 7 weight% fat. Levy et al. (3) reported that lipolytic activity in EFA-deficient rats was unchanged compared with control rats. Our present results in EFA-deficient mice are compatible with this observation. The appearance of [ Rather than differences in fat digestion (lipolysis), it could have been expected that alterations in bile formation contributed to fat malabsorption in EFA-deficient mice, in analogy to the situation in EFA-deficient rats (6) . The pathophysiology of EFA deficiency-associated fat malabsorption in mice could be due to decreased biliary bile salt secretion rates, analogous to previous data in rats. However, bile flow and biliary bile salt and phospholipid secretion rates were increased during EFA deficiency. Robins and Fasulo (25) reported that EFA-deficient hamsters have increased hepatic bile flow and biliary bile salt and cholesterol secretion compared to controls. It is not known, however, whether EFA-deficient hamsters have a decreased coefficient of fat absorption. Our observation in EFA-deficient mice, together with the available data on EFAdeficient rats and hamsters, indicate that the effects of EFA deficiency on bile formation are species specific. Present data exclude that EFA-deficient fat malabsorption is due to decreased rates of biliary bile salt secretion in mice, in contrast to the situation in rats (3;6) . Theoretically, an increase in the contribution of hydrophilic bile salts (to total bile salts) could contribute to impaired solubilization of dietary fats.
Yet, biliary bile salt composition was virtually unchanged in EFA-deficient mice compared to controls. The increased biliary secretion rate of bile salts, immediately after interruption of the enterohepatic circulation, strongly suggests an expansion of the bile salt pool size in EFA deficiency.
Bile salts negatively affect their own biosynthesis by repressing the expression of Cyp7A via the FXR-SHP1-LRH1-Cyp7A pathway, with Cyp7A encoding the enzyme cholesterol 7A-hydroxylase that catalyzes the first step of the neutral pathway in bile salt synthesis (26) (27) (28) (29) (30) . In our experiments however, Cyp7A and Cyp27 mRNA levels were similar in livers from EFAS and EFAD mice. We speculate that EFA deficiency in mice impairs the capacity of bile salts to exert negative feedback inhibition on their own hepatic biosynthesis, but the mechanism hereof remains unclear.
Not only biliary bile salts, but also biliary phospholipids play a role in dietary fat absorption, for example in supplying surface components for the assembly of chylomicron particles in enterocytes (31;32) . Under physiological conditions, overall fat absorption in Mdr2 -/-mice is only slightly decreased compared to control mice (95 vs. 98%), based on 72h fecal fat balance measurements. On the other hand, kinetics of chylomicron formation are clearly delayed in Mdr2 -/-mice (33) . Therefore, a quantitative alteration in biliary phospholipid secretion was not likely to contribute to EFA deficiency-associated fat malabsorption. Yet, fat malabsorption during EFA deficiency could still be due to qualitative changes in biliary phospholipid composition. Replacement of polyunsaturated acyl chains (linoleoyl-, arachidonoyl-) by monounsaturated or saturated species could theoretically be responsible for impaired chylomicron assembly and secretion. In accordance with findings by Bennett Clark et al. in EFA-deficient rats (4) , the acyl chain composition of biliary PL in EFA-deficient mice showed less essential (i.e., C18:2n-6 and C20:4n-6) and more non-essential fatty acids (i.e., C18:1n-9, C18:1n-7, C16:1n-7 mice, as in EFA-deficient wildtype controls, bile flow and biliary bile salt secretion were increased. Based on the similar fat absorption coefficients we found in EFA-deficient mice with and without biliary PL secretion, we conclude that the effect of biliary PL acyl chain composition is not of pathophysiological relevance for EFA deficiency-associated fat malabsorption.
Rather than to alterations in bile secretion, fat malabsorption during EFA deficiency may be due to other steps involved in fat absorption. Intestinal mucosal phospholipids normally contain large amounts of C18:2n-6 and C20:4n-6, and during EFA deficiency the levels of these fatty acids are markedly decreased (34) (35) (36) . The resultant structural changes in membranes, and the increased cellular turnover rate in the intestinal mucosa reported in EFA-deficient rats (5) could be responsible for decreased dietary fat absorption. Based on our study and previous studies in EFA-deficient rats (3;4) , the intraluminal events involved in fat absorption (i.e., lipolysis of dietary triglyceride by pancreatic lipase, solubilization of lipolytic products and uptake by the enterocyte) seem to be relatively undisturbed in EFA deficiency. By inference, it is therefore more likely that defects in one of the several intracellular events (i.e., re-esterification, chylomicron assembly and/or secretion) are involved in EFA deficiency-associated fat malabsorption.
